 | Akebia Therapeutics (NASDAQ:AKBA) Downgraded by Zacks Investment Research to "Hold"
marketbeat.com - July 15 at 4:54 PM |
 | Akebia Therapeutics Announces Data on Different Dosing Regimens of Ferric Citrate for Iron Deficiency Anemia Presented at 57th
www.bloomberg.com - August 3 at 9:36 AM |
 | Akebia Therapeutics to Report Second Quarter 2020 Financial Results
finance.yahoo.com - August 3 at 9:36 AM |
 | Akebia Therapeutics (NASDAQ:AKBA) Stock Price Down 6.2%
www.americanbankingnews.com - July 31 at 8:18 PM |
| Morgan Stanley Boosts Akebia Therapeutics (NASDAQ:AKBA) Price Target to $12.00
www.americanbankingnews.com - July 16 at 6:05 AM |
| Akebia Therapeutics (NASDAQ:AKBA) Receives "Buy" Rating from HC Wainwright
www.americanbankingnews.com - July 16 at 4:33 AM |
 | Akebia launches vadadustat study in COVID-19 complication
seekingalpha.com - July 14 at 12:13 PM |
| Akebia Announces Initiation of Investigator-Sponsored Study Evaluating Vadadustat for Prevention and Treatment of ARDS in Patients Hospitalized with COVID-19
finance.yahoo.com - July 14 at 12:13 PM |
| Akebia Initiates Vadadustat Study In Covid-19 Patients
finance.yahoo.com - July 14 at 12:13 PM |
| Akebia Therapeutics Inc (NASDAQ:AKBA) Given Average Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - July 14 at 6:30 AM |
|
| What Is The Ownership Structure Like For Akebia Therapeutics, Inc. (NASDAQ:AKBA)?
finance.yahoo.com - July 6 at 1:23 PM |
| Akebia's Vadadustat OK'd in Japan for CKD anemia
seekingalpha.com - June 29 at 12:10 PM |
| Akebia Therapeutics Announces Approval of Vadadustat in Japan for the Treatment of Anemia Due to Chronic Kidney Disease in Dialysis-Dependent and Non-Dialysis Dependent Adult Patients
finance.yahoo.com - June 29 at 12:10 PM |
| Hedge Funds Are Buying Akebia Therapeutics Inc (AKBA)
finance.yahoo.com - June 23 at 3:41 PM |
| Akebia Therapeutics Launches AkebiaShares, a Peer-to-Peer Educational Program Series for the Renal Community
finance.yahoo.com - June 22 at 1:21 PM |
| Akebia names finance chief
seekingalpha.com - June 18 at 6:45 PM |
| Akebia Therapeutics Announces New Chief Financial Officer
finance.yahoo.com - June 18 at 6:45 PM |
 | Akebia Therapeutics Inc.
www.barrons.com - June 17 at 2:30 PM |
| Is Akebia Therapeutics (AKBA) Stock Outpacing Its Medical Peers This Year?
finance.yahoo.com - June 16 at 1:49 PM |
| Akebia Therapeutics Announces Data on Different Dosing Regimens of Ferric Citrate for Iron Deficiency Anemia Presented at 57th ERA-EDTA Virtual Congress
finance.yahoo.com - June 10 at 8:50 AM |
| Akebia Therapeutics: A Clear Path To A Blockbuster CKD-Anemia Treatment
seekingalpha.com - May 31 at 11:44 PM |
| Akebia Therapeutics to Present at Jefferies Virtual Global Healthcare Conference
finance.yahoo.com - May 26 at 8:53 AM |
| Akebia Therapeutics Announces Change to Virtual Annual Meeting of Stockholders
finance.yahoo.com - May 21 at 6:52 PM |
| Akebia Therapeutics Announces Full Exercise of Underwriters' Option to Purchase Additional Shares
finance.yahoo.com - May 19 at 8:55 PM |
| Akebia Therapeutics Announces Full Exercise of Underwriters' Option to Purchase Additional Shares
finance.yahoo.com - May 19 at 8:55 PM |
| Akebia announces filing in Japan expanded use of Riona tablets
seekingalpha.com - May 18 at 6:37 PM |
| Akebia announces filing in Japan for expanded use of Riona
seekingalpha.com - May 18 at 1:37 PM |
| Akebia Therapeutics Announces Collaboration Partner's Submission of Supplemental New Drug Application for Use of Riona® (ferric citrate hydrate) to Treat Adult Patients with Iron Deficiency Anemia in Japan
finance.yahoo.com - May 18 at 8:37 AM |
|
| Akebia Therapeutics, Inc. (AKBA) Shares March Higher, Can It Continue?
finance.yahoo.com - May 13 at 1:59 PM |
| Akebia Therapeutics prices upsized equity offering, Shares down 5% after hours
seekingalpha.com - May 12 at 2:24 AM |
| Akebia Therapeutics Announces Pricing of Upsized Public Offering of Common Stock
finance.yahoo.com - May 11 at 9:24 PM |
| How Akebia Therapeutics (AKBA) Stock Stands Out in a Strong Industry
finance.yahoo.com - May 11 at 4:19 PM |
| Akebia Therapeutics Announces Proposed Public Offering of Common Stock
finance.yahoo.com - May 11 at 4:19 PM |
| Edited Transcript of AKBA earnings conference call or presentation 5-May-20 12:30pm GMT
finance.yahoo.com - May 8 at 10:37 PM |
| Akebia Therapeutics to Present at RBC Capital Markets Global Healthcare Virtual Conference
finance.yahoo.com - May 8 at 5:37 PM |
| US$17.13 - That's What Analysts Think Akebia Therapeutics, Inc. (NASDAQ:AKBA) Is Worth After These Results
finance.yahoo.com - May 7 at 5:55 PM |
| US$17.13 - That's What Analysts Think Akebia Therapeutics, Inc. (NASDAQ:AKBA) Is Worth After These Results
finance.yahoo.com - May 7 at 5:55 PM |
| Akebia Spikes 38% On Pivotal Trial Readout; And Further Upside Lies Ahead
finance.yahoo.com - May 6 at 4:59 AM |
 | Stock Alert: Akebia Therapeutics Up 25% As Drug Trial Achieves Positive Results
www.nasdaq.com - May 5 at 5:28 PM |
| Akebia Therapeutics (AKBA) Reports Q1 Loss, Tops Revenue Estimates
www.nasdaq.com - May 5 at 5:28 PM |
 | Akebia's shares jump on late-stage clinical trial results for kidney disease drug
www.msn.com - May 5 at 8:49 AM |
 | Vifor Pharma Announces Akebia’s Positive Top-Line Results From Global Phase-III Program of vadadustat for Treatment of Anaemia Due to Chronic Kidney Disease in Adult Dialysis ...
www.businesswire.com - May 5 at 8:49 AM |
| Akebia Therapeutics, Inc. 2020 Q1 - Results - Earnings Call Presentation
seekingalpha.com - May 5 at 8:49 AM |
| Akebia up 25% premarket on positive vadadustat data
seekingalpha.com - May 5 at 8:49 AM |
| Akebia's shares jump on late-stage clinical trial results for kidney disease drug
finance.yahoo.com - May 5 at 8:49 AM |
| Akebia Announced Positive Top-Line Results from Global Phase 3 Program of Vadadustat for Treatment of Anemia Due to Chronic Kidney Disease in Adult Patients on Dialysis; Reports First Quarter 2020 Financial Results
finance.yahoo.com - May 5 at 8:49 AM |
| Akebia Therapeutics to Report First Quarter 2020 Financial Results and Discuss Recent Business Highlights
finance.yahoo.com - April 28 at 9:13 AM |
| INVESTOR ALERT: Fields Kupka & Shukurov LLP Is Investigating Akebia Therapeutics, Inc. for Potential Breach of Fiduciary Duty Claims.
finance.yahoo.com - April 10 at 11:00 PM |
| Akebia Therapeutics Appoints Myles Wolf, M.D., M.M.Sc., Chief of Nephrology and Professor at Duke University School of Medicine, to Board of Directors
finance.yahoo.com - April 7 at 5:37 PM |
| Edited Transcript of AKBA earnings conference call or presentation 10-Mar-20 1:00pm GMT
finance.yahoo.com - March 26 at 11:43 PM |
| Akebia Therapeutics to Present Research at NKF 2020 Spring Clinical Meetings Live Virtual Conference
finance.yahoo.com - March 23 at 12:23 PM |
